InvestorsHub Logo
Followers 28
Posts 3331
Boards Moderated 0
Alias Born 12/05/2021

Re: exwannabe post# 428990

Wednesday, 12/22/2021 1:43:04 PM

Wednesday, December 22, 2021 1:43:04 PM

Post# of 724627
so you have no problem asserting NWBO management and its scientific board of directors are swindlers, crooks for not disclosing a failed trial and will be investigated by DOJ and or SEC?

https://westwicke.com/2019/11/keys-to-successful-disclosure-of-clinical-trial-data-and-milestones/

The bad news: Failing to properly disclose material events regarding clinical trial data may result in more than harm to company’s reputation. It could lead to an investigation by the SEC and/or DOJ if the agencies believe that the company has intentionally deceived investors. The FDA may assist these inquiries, and in fact, the FDA and SEC now have a specified mechanism in place that facilitates FDA reporting to the SEC if they come to believe that a company may have made a false or misleading statement to the investors. SEC and DOJ investigations pose a much graver risk than ordinary commercial litigation, as consequences may include substantial fines for the company and its executives, bars on serving as an officer at a publicly traded company for a period of time, and, in extreme cases, criminal prosecution including potential jail time.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News